Marziali, M. E., Kooij, K. W., Zhang, W., Budu, M., Martins, S. S., Montaner, J. S. G., & Hogg, R. S. (2025). Fatal overdoses among people with HIV experiencing nonfatal overdoses in British Columbia, Canada. AIDS, 39(3), 328–330. https://doi.org/10.1097/qad.0000000000004039

Freisthler, B., Chahine, R. A., Villani, J., Chandler, R., Feaster, D. J., Slavova, S., Defiore-Hyrmer, J., Walley, A. Y., Kosakowski, S., Aldridge, A., Barbosa, C., Bhatta, S., Brancato, C., Bridden, C., Christopher, M., Clarke, T., David, J., D’Costa, L., Ewing, I., … Oga, E. A. (2024). Communities That HEAL Intervention and Mortality Including Polysubstance Overdose Deaths. JAMA Network Open, 7(10), e2440006. https://doi.org/10.1001/jamanetworkopen.2024.40006

Santaella-Tenorio, J., Zapata-López, J. S., Fidalgo, T. M., Tardelli, V. S., Segura, L. E., Cerda, M., & Martins, S. S. (2024). Trends in Nonfatal Overdose Rates Due to Alcohol and Prescription and Illegal Substances in Colombia, 2010‒2021. American Journal of Public Health, 114(11), 1252–1260. https://doi.org/10.2105/ajph.2024.307786

Bruzelius, E., Palamar, J. J., Fitzgerald, N. D., Cottler, L. B., Carr, T. C., & Martins, S. S. (2024). Law enforcement fentanyl seizures and overdose mortality in US counties, 2013–2020. Drug and Alcohol Dependence, 262, 111400. https://doi.org/10.1016/j.drugalcdep.2024.111400

Martins, S. S., Segura, L. E., Marziali, M. E., Bruzelius, E., Levy, N. S., Gutkind, S., Santarin, K., Sacks, K., & Fox, A. (2024). Higher unemployment benefits are associated with reduced drug overdose mortality in the United States before and during the COVID-19 pandemic. International Journal of Drug Policy, 130, 104522. https://doi.org/10.1016/j.drugpo.2024.104522

Eschliman, E. L., Choe, K., DeLucia, A., Addison, E., Jackson, V. W., Murray, S. M., German, D., Genberg, B. L., & Kaufman, M. R. (2024). First-hand accounts of structural stigma toward people who use opioids on Reddit. Social Science & Medicine, 347, 116772. https://doi.org/10.1016/j.socscimed.2024.116772

Cerdá, M., Hamilton, A. D., Hyder, A., Rutherford, C., Bobashev, G., Epstein, J. M., Hatna, E., Krawczyk, N., El-Bassel, N., Feaster, D. J., & Keyes, K. M. (2024). Simulating the Simultaneous Impact of Medication for Opioid Use Disorder and Naloxone on Opioid Overdose Death in Eight New York Counties. Epidemiology, 35(3), 418–429. https://doi.org/10.1097/ede.0000000000001703

Fink, D. S., Schleimer, J. P., Keyes, K. M., Branas, C. C., Cerdá, M., Gruenwald, P., & Hasin, D. (2024). Social and economic determinants of drug overdose deaths: a systematic review of spatial relationships. Social Psychiatry and Psychiatric Epidemiology, 59(7), 1087–1112. https://doi.org/10.1007/s00127-024-02622-4

Nesoff, E. D., Meisel, Z. F., Saeed, H., & Martins, S. S. (2024). Neighborhood and Individual Disparities in Community-Based Naloxone Access for Opioid Overdose Prevention. Journal of Urban Health, 101(1), 64–74. https://doi.org/10.1007/s11524-023-00821-z

Otufowora, A., Egan, K. L., Chaudhari, P. V., Okusanya, A. A., Ogidan, A. O., & Cottler, L. B. (2023). Drug Deactivation Pouches for Primary Prevention of Opioid Overdose: Perceptions and Attitudes of Community Members. The Journal of the American Board of Family Medicine, 37(1), 112–117. https://doi.org/10.3122/jabfm.2023.230227r1

Rockett, I. R. H., Ali, B., Caine, E. D., Shepard, D. S., Banerjee, A., Nolte, K. B., Connery, H. S., Larkin, G. L., Stack, S., White, F. M. M., Jia, H., Cossman, J. S., Feinberg, J., Stover, A. N., & Miller, T. R. (2023). Escalating costs of self-injury mortality in the 21st century United States: an interstate observational study. BMC Public Health, 23(1). https://doi.org/10.1186/s12889-023-15188-8

Khan, M. R., Hoff, L., Elliott, L., Scheidell, J. D., Pamplin, J. R., Townsend, T. N., Irvine, N. M., & Bennett, A. S. (2023). Racial/ethnic disparities in opioid overdose prevention: comparison of the naloxone care cascade in White, Latinx, and Black people who use opioids in New York City. Harm Reduction Journal, 20(1). https://doi.org/10.1186/s12954-023-00736-7

Mannes, Z. L., Wheeler-Martin, K., Terlizzi, K., Hasin, D. S., Perry, A., Pamplin, J. R., Crystal, S., Cerdá, M., & Martins, S. S. (2023). Risks of opioid overdose among New York State Medicaid recipients with chronic pain before and during the COVID-19 pandemic. Preventive Medicine, 177, 107789. https://doi.org/10.1016/j.ypmed.2023.107789

Tipping, A. D., Nowels, M., Moore, C., Samples, H., Crystal, S., Olfson, M., Williams, A. R., & Heaps-Woodruff, J. (2024). Association of medications for opioid use disorder with reduced risk of repeat opioid overdose in Medicaid: A cohort study. Journal of Substance Use and Addiction Treatment, 157, 209218. https://doi.org/10.1016/j.josat.2023.209218

Hoffman, K. L., Milazzo, F., Williams, N. T., Samples, H., Olfson, M., Diaz, I., Doan, L., Cerda, M., Crystal, S., & Rudolph, K. E. (2023). Independent and joint contributions of physical disability and chronic pain to incident opioid use disorder and opioid overdose among Medicaid patients. Psychological Medicine, 54(7), 1419–1430. https://doi.org/10.1017/s003329172300332x

Tatar, M., Faraji, M. R., Keyes, K., Wilson, F. A., & Jalali, M. S. (2023). Social vulnerability predictors of drug poisoning mortality: A machine learning analysis in the United States. The American Journal on Addictions, 32(6), 539–546. Portico. https://doi.org/10.1111/ajad.13445

Shiue, K. Y., Austin, A. E., Naumann, R. B., Aiello, A. E., Marshall, S. W., & Golightly, Y. M. (2023). Age, period and cohort-related trends in prescription opioid use in the USA, 1999–2018. Journal of Epidemiology and Community Health, 77(11), 714–720. https://doi.org/10.1136/jech-2023-220701

Bushnell, G. A., Rynn, M. A., Gerhard, T., Keyes, K. M., Hasin, D. S., Cerdá, M., Nyandege, A., & Olfson, M. (2023). Drug overdose risk with benzodiazepine treatment in young adults: Comparative analysis in privately and publicly insured individuals. Addiction, 119(2), 356–368. Portico. https://doi.org/10.1111/add.16359

Williams, A. R., Mauro, C. M., Feng, T., Waples, J., Martins, S. S., & Haney, M. (2023). Adult Medical Cannabinoid Use and Changes in Prescription Controlled Substance Use. Cannabis and Cannabinoid Research, 8(5), 933–941. https://doi.org/10.1089/can.2021.0212

Bunting, A. M., Shearer, R., Linden-Carmichael, A. N., Williams, A. R., Comer, S. D., Cerdá, M., & Lorvick, J. (2023). Are you thinking what I’m thinking? Defining what we mean by “polysubstance use.” The American Journal of Drug and Alcohol Abuse, 50(1), 1–7. https://doi.org/10.1080/00952990.2023.2248360

Bianco, M. C. M., Tardelli, V. S., Brooks, E. R., Areco, K. C. N., Tardelli, A. O., Bandiera-Paiva, P., Santaella, J., Segura, L. E., Castaldelli-Maia, J. M., Martins, S. S., & Fidalgo, T. M. (2023). Drug overdose deaths in Brazil between 2000 and 2020: an analysis of sociodemographics and intentionality. Brazilian Journal of Psychiatry. https://doi.org/10.47626/1516-4446-2022-3023

Olfson, M., Cosgrove, C. M., Wall, M. M., & Blanco, C. (2023). Fatal Drug Overdose Risks of Health Care Workers in the United States. Annals of Internal Medicine, 176(8), 1081–1088. https://doi.org/10.7326/m23-0902

Pamplin, J. R., King, C., Cooper, C., Bennett, A. S., Elliott, L., Davis, C. S., Rouhani, S., & Townsend, T. N. (2023). Pathways to racial disparities in the effects of Good Samaritan Laws: A mixed methods pilot study. Drug and Alcohol Dependence, 249, 110823. https://doi.org/10.1016/j.drugalcdep.2023.110823

Allen, B., Basaraba, C., Corbeil, T., Rivera, B. D., Levin, F. R., Martinez, D. M., Schultebraucks, K., Henry, B. F., Pincus, H. A., Arout, C., & Krawczyk, N. (2023). Racial differences in COVID-19 severity associated with history of substance use disorders and overdose: Findings from multi-site electronic health records in New York City. Preventive Medicine, 172, 107533. https://doi.org/10.1016/j.ypmed.2023.107533

Samples, H., Nowels, M. A., Williams, A. R., Olfson, M., & Crystal, S. (2023). Buprenorphine After Nonfatal Opioid Overdose: Reduced Mortality Risk in Medicare Disability Beneficiaries. American Journal of Preventive Medicine, 65(1), 19–29. https://doi.org/10.1016/j.amepre.2023.01.037

Tardelli, V., Xu, K. Y., Bisaga, A., Levin, F. R., Fidalgo, T. M., & Grucza, R. A. (2023). Prescription amphetamines in people with opioid use disorder and co-occurring psychostimulant use disorder initiating buprenorphine: an analysis of treatment retention and overdose risk. BMJ Mental Health, 26(1), e300728. https://doi.org/10.1136/bmjment-2023-300728

Olfson, M., Waidmann, T., King, M., Pancini, V., & Schoenbaum, M. (2023). Opioid Prescribing and Suicide Risk in the United States. American Journal of Psychiatry, 180(6), 418–425. https://doi.org/10.1176/appi.ajp.22020102

Fink, D. S., Keyes, K. M., Branas, C., Cerdá, M., Gruenwald, P., & Hasin, D. (2023). Understanding the differential effect of local socio‐economic conditions on the relation between prescription opioid supply and drug overdose deaths in US counties. Addiction, 118(6), 1072–1082. Portico. https://doi.org/10.1111/add.16123

Olfson, M., Cosgrove, C. M., Wall, M. M., & Blanco, C. (2023). Living Alone and Drug Overdose Deaths in the US. JAMA Psychiatry, 80(6), 645. https://doi.org/10.1001/jamapsychiatry.2023.0596

Yule, A. M., Basaraba, C., Mail, V., Bereznicka, A., Cates-Wessel, K., & Levin, F. R. (2023). A cross sectional survey of provider experiences with patient drug overdose death. Journal of Substance Use and Addiction Treatment, 148, 209008. https://doi.org/10.1016/j.josat.2023.209008

Brandt, L., Hu, M.-C., Liu, Y., Castillo, F., Odom, G. J., Balise, R. R., Feaster, D. J., Nunes, E. V., & Luo, S. X. (2023). Risk of Experiencing an Overdose Event for Patients Undergoing Treatment With Medication for Opioid Use Disorder. American Journal of Psychiatry, 180(5), 386–394. https://doi.org/10.1176/appi.ajp.20220312

Wilkerson, A. H., Sharma, M., Davis, R. E., Stephens, P. M., Kim, R. W., Bhati, D., & Nahar, V. K. (2023). Predisposing, enabling and reinforcing factors associated with opioid addiction helping behaviour in tri-state Appalachian counties: application of the PRECEDE–PROCEED model–cross-sectional analysis. BMJ Open, 13(5), e066147. https://doi.org/10.1136/bmjopen-2022-066147

CERDÁ, M., KRAWCZYK, N., & KEYES, K. (2023). The Future of the United States Overdose Crisis: Challenges and Opportunities. The Milbank Quarterly, 101(S1), 478–506. Portico. https://doi.org/10.1111/1468-0009.12602

Chandler, R., Nunes, E. V., Tan, S., Freeman, P. R., Walley, A. Y., Lofwall, M., Oga, E., Glasgow, L., Brown, J. L., Fanucchi, L., Beers, D., Hunt, T., Bowers-Sword, R., Roeber, C., Baker, T., & Winhusen, T. J. (2023). Community selected strategies to reduce opioid-related overdose deaths in the HEALing (Helping to End Addiction Long-term SM) communities study. Drug and Alcohol Dependence, 245, 109804. https://doi.org/10.1016/j.drugalcdep.2023.109804

West, B. S., Diaz, J. E., Philbin, M. M., & Mauro, P. M. (2023). Past-year medical and non-medical opioid use by HIV status in a nationally representative US sample: Implications for HIV and substance use service integration. Journal of Substance Use and Addiction Treatment, 147, 208976. https://doi.org/10.1016/j.josat.2023.208976

Sacco, D. L., & Martins, S. S. (2022). Characteristics of Nonfatal Opioid Overdose in Emergency Department Patients Surviving to Discharge or Hospital Admission. Journal of Studies on Alcohol and Drugs. https://doi.org/10.15288/jsad.22-00204

Olfson, M., Waidmann, T., King, M., Pancini, V., & Schoenbaum, M. (2022). Population-Based Opioid Prescribing and Overdose Deaths in the USA: an Observational Study. Journal of General Internal Medicine, 38(2), 390–398. https://doi.org/10.1007/s11606-022-07686-z

Pamplin, J. R., Rouhani, S., Davis, C. S., King, C., & Townsend, T. N. (2023). Persistent Criminalization and Structural Racism in US Drug Policy: The Case of Overdose Good Samaritan Laws. American Journal of Public Health, 113(S1), S43–S48. https://doi.org/10.2105/ajph.2022.307037

Michelassi, F., Bloom, J., Su, M. K., & Naqvi, I. A. (2022). Levofloxacin-associated transient mixed sensorimotor lacunar syndrome. BMJ Case Reports, 15(12), e252052. https://doi.org/10.1136/bcr-2022-252052

Bruzelius, E., & Martins, S. S. (2022). US Trends in Drug Overdose Mortality Among Pregnant and Postpartum Persons, 2017-2020. JAMA, 328(21), 2159. https://doi.org/10.1001/jama.2022.17045

Nesoff, E. D., Wiebe, D. J., & Martins, S. S. (2022). City streetscapes and neighborhood characteristics of fatal opioid overdoses among people experiencing homelessness who use drugs in New York City, 2017–2019. International Journal of Drug Policy, 110, 103904. https://doi.org/10.1016/j.drugpo.2022.103904

Krawczyk, N., Rivera, B. D., Jent, V., Keyes, K. M., Jones, C. M., & Cerdá, M. (2022). Has the treatment gap for opioid use disorder narrowed in the U.S.?: A yearly assessment from 2010 to 2019”. International Journal of Drug Policy, 110, 103786. https://doi.org/10.1016/j.drugpo.2022.103786

Williams, A. R., Johnson, K. A., Thomas, C. P., Reif, S., Socías, M. E., Henry, B. F., Neighbors, C., Gordon, A. J., Horgan, C., Nosyk, B., Drexler, K., Krawczyk, N., Gonsalves, G. S., Hadland, S. E., Stein, B. D., Fishman, M., Kelley, A. T., Pincus, H. A., & Olfson, M. (2022). Commentary Article: Opioid use Disorder Cascade of Care Framework Design: A Roadmap. Substance Abuse, 43(1), 1207–1214. https://doi.org/10.1080/08897077.2022.2074604

Bushnell, G. A., Gerhard, T., Keyes, K., Hasin, D., Cerdá, M., & Olfson, M. (2022). Association of Benzodiazepine Treatment for Sleep Disorders With Drug Overdose Risk Among Young People. JAMA Network Open, 5(11), e2243215. https://doi.org/10.1001/jamanetworkopen.2022.43215

Hamilton, L. K., Wheeler-Martin, K., Davis, C. S., Martins, S. S., Samples, H., & Cerdá, M. (2022). A modified Delphi process to identify experts’ perceptions of the most beneficial and harmful laws to reduce opioid-related harm. International Journal of Drug Policy, 108, 103809. https://doi.org/10.1016/j.drugpo.2022.103809

Rudolph, K. E., Gimbrone, C., Matthay, E. C., Díaz, I., Davis, C. S., Keyes, K., & Cerdá, M. (2022). When Effects Cannot be Estimated: Redefining Estimands to Understand the Effects of Naloxone Access Laws. Epidemiology, 33(5), 689–698. https://doi.org/10.1097/ede.0000000000001502

Ross, J. A., Malone, P. K., & Levy, S. (2022). The Impact of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic on Substance Use in the United States. Clinical Infectious Diseases, 75(Supplement_1), S81–S85. https://doi.org/10.1093/cid/ciac311

Jones, J. D., Campbell, A. N., Brandt, L., Metz, V. E., Martinez, S., Wall, M., Corbeil, T., Andrews, H., Castillo, F., Neale, J., Strang, J., Ross, S., & Comer, S. D. (2022). A randomized clinical trial of the effects of brief versus extended opioid overdose education on naloxone utilization outcomes by individuals with opioid use disorder. Drug and Alcohol Dependence, 237, 109505. https://doi.org/10.1016/j.drugalcdep.2022.109505

Lui, B., White, R. S., Aaronson, J., & Hoyler, M. (2022). Economic burden of drug overdose deaths before and during the COVID-19 pandemic in the USA. Journal of Comparative Effectiveness Research, 11(9), 643–648. https://doi.org/10.2217/cer-2021-0314

Keyes, K. M., & Cerdá, M. (2022). Dynamics of drug overdose in the 20th and 21st centuries: The exponential curve was not inevitable, and continued increases are preventable. International Journal of Drug Policy, 104, 103675. https://doi.org/10.1016/j.drugpo.2022.103675